<TABLE>
<TR><TD COLSPAN=5><a name="description"></a>&nbsp;<p><p style='text-align: center;'><strong>1.C.90 The Carnocyclin A (Carnocyclin) Family</strong></p>
<p style='text-align: left;'>Carnocyclin A (CclA) is a 60-amino acid circular bacteriocin produced
by <em>Carnobacterium maltaromaticum</em> UAL307. It exhibits potent activity
against many Gram-positive bacteria. Lipid bilayer and single channel
recording techniques were applied to study the molecular mechanisms by
which CclA interacts with the lipid membrane and exerts its
antimicrobial effects. <span id='ref6584.19463781' class='cite'>Gong <em>et al.</em> 2009</span> showed that CclA can form ion channels
with a conductance of 35 pS in a 150 mM NaCl solution. Channel
activity displays a linear current-voltage relationship, is anion-selective, and
its activation is strongly voltage-dependent. The formation of ion
channels by CclA is driven by the presence of a negative membrane
potential and may result in dissipation of the membrane potential.</p>
<p style='text-align: left;'>An amide bond links
the N and C termini of this bacteriocin, imparting stability and
structural integrity to this peptide. Several other circular bacteriocins have been reported, yet only
one (enterocin AS-48) has been structurally characterized.&nbsp;<span id='ref.18552180' class='cite'>Martin-Visscher <em>et al.</em> (2008;</span><span id='ref.19692336' class='cite'>2009)</span> have determined the solution structure of CclA by NMR and further examined
its anion binding and membrane channel properties. The results revealed
that CclA preferentially binds halide anions and has a structure that
is surprisingly similar to that of AS-48 despite low sequence identity,
a different oligomeric state, and disparate function. CclA folds into a
compact globular bundle, comprised of four helices surrounding a
hydrophobic core. NMR studies show two fluoride ion binding modes for
CclA. Although other circular bacteriocins
are likely to have diverse mechanisms of action, many may have a common
structural motif. This shared three-dimensional arrangement resembles
the fold of mammalian saposins, peptides that either directly lyse
membranes or serve as activators of lipid-degrading enzymes (<span id='ref6738.19692336' class='cite'>Martin-Visscher <em>et al.</em>, 2009</span>).</p>
<p style='text-align: left;'>The reaction catalized by Carnocyclin A is:</p>
<p style='text-align: center;'>Ions (in) &rarr; Ions (out)</p><BR></TD></TR><TR><TD COLSPAN=5><HR>This family belongs to the <A HREF="superfamily.php?id=37">Circular Bacterial Bacteriocin (CBB) Superfamily</A>.<BR><HR></TD></TR><TR><TD COLSPAN=5><a name="references"></a>&nbsp;<p><B>References:</B><P></TD></TR><TR><TD COLSPAN=5>Gong X., Martin-Visscher LA., Nahirney D., Vederas JC. and Duszyk M. (2009). The circular bacteriocin, carnocyclin A, forms anion-selective channels in lipid bilayers. Biochim Biophys Acta. 1788(9):1797-803.<BR><HR></TD></TR><TR><TD COLSPAN=5>Martin-Visscher, L.A., M.J. van Belkum, S. Garneau-Tsodikova, R.M. Whittal, J. Zheng, L.M. McMullen, and J.C. Vederas. (2008).  Isolation and characterization of carnocyclin a, a novel circular bacteriocin produced by <i>Carnobacterium</i> maltaromaticum UAL307.  Appl. Environ. Microbiol. 74: 4756-4763.<BR><HR></TD></TR><TR><TD COLSPAN=5>Martin-Visscher, L.A., X. Gong, M. Duszyk, and J.C. Vederas. (2009).  The three-dimensional structure of carnocyclin A reveals that many circular bacteriocins share a common structural motif.  J. Biol. Chem. 284: 28674-28681.<BR><HR></TD></TR><TR><TD COLSPAN=5>Treberg, J.R., C.L. Quinlan, and M.D. Brand. (2011).  Evidence for two sites of superoxide production by mitochondrial NADH-ubiquinone oxidoreductase (complex I).  J. Biol. Chem. 286: 27103-27110.<BR><HR></TD></TR><TR><TD COLSPAN=5>van Belkum, M.J., L.A. Martin-Visscher, and J.C. Vederas. (2011).  Structure and genetics of circular bacteriocins.  Trends Microbiol. 19: 411-418.<BR><HR></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="1.C.90.1.1"></A><A HREF="tcprotein.php?substrate=1.C.90.1.1&tcname=">1.C.90.1.1</a></TD><TD><b><font color=#3333CC><p>Cyclic bacteriocin, Group I, carnocyclin, (CdlA; 64 aas; 1 TMS) (<span id="ref7895.21664137" class="cite">van Belkum <em>et al.</em>, 2011</span>) (3-d solution structure: 2KJF_A; forms anion selective pores; Similar to As-48 (1.C.28.1.1)) (<span id="ref6738.19692336" class="cite">Martin-Visscher <em>et al.</em>, 2009</span>)</p></TD><TD><b><font color=#3333CC><p>Firmicutes</p></TD><TD><b><font color=#3333CC><p>CdlA of <em>Carnobacterium maltaromaticum </em>(B2MVM5)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="1.C.90.1.2"></A><A HREF="tcprotein.php?substrate=1.C.90.1.2&tcname=">1.C.90.1.2</a></TD><TD><b><font color=#3333CC><p>Cyclic bacteriocin, Group I, Garvicin ML (GarML; 63 aas; 1 or 2 TMSs)</p></TD><TD><b><font color=#3333CC><p>Firmicutes</p></TD><TD><b><font color=#3333CC><p>GarML of Lactococcus garvieae (D2KC49)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="1.C.90.1.3"></A><A HREF="tcprotein.php?substrate=1.C.90.1.3&tcname=">1.C.90.1.3</a></TD><TD><b><font color=#3333CC><p>Cyclic bacteriocin, Group I Uberolysin, UblA (70 aas; 1 TMS) (<span id="ref7895.21664137" class="cite">van Belkum <em>et al.</em>, 2011</span>)</p></TD><TD><b><font color=#3333CC><p>Firmicutes</p></TD><TD><b><font color=#3333CC><p>UblA of <em>Streptococcus uberis</em> (A5H1G9)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="1.C.90.2.1"></A><A HREF="tcprotein.php?substrate=1.C.90.2.1&tcname=">1.C.90.2.1</a></TD><TD><b><font color=#3333CC><p>Putative bacteriocin (73 aas; 2 TMSs)</p></TD><TD><b><font color=#3333CC><p>Firmicutes</p></TD><TD><b><font color=#3333CC><p>Putative bacteriocin of <em>Staphylococcus aureus </em>(Q99X21)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="1.C.90.2.2"></A><A HREF="tcprotein.php?substrate=1.C.90.2.2&tcname=">1.C.90.2.2</a></TD><TD><b><font color=#3333CC><p>Putative bacteriocin &nbsp;(118 aas; 3 TMSs)</p></TD><TD><b><font color=#3333CC><p>Firmicutes</p></TD><TD><b><font color=#3333CC><p>Putative bacteriocin of <em>Bacillus thuringiensis </em>(A0RKJ6)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR><TD COLSPAN=5><B>Examples:</B><P></TD></TR><TR bgcolor="#99ccff"><TD>TC#</TD><TD>Name</TD><TD>Organismal Type</TD><TD>Example</TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="1.C.90.3.1"></A><A HREF="tcprotein.php?substrate=1.C.90.3.1&tcname=">1.C.90.3.1</a></TD><TD><b><font color=#3333CC><p>Putative bacteriocin (69 aas; 1 TMS)&nbsp;</p></TD><TD><b><font color=#3333CC><p>Firmicutes</p></TD><TD><b><font color=#3333CC><p>Putative bacteriocin of <em>Clostridium perfringens </em>(Q0SUX0)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="1.C.90.3.2"></A><A HREF="tcprotein.php?substrate=1.C.90.3.2&tcname=">1.C.90.3.2</a></TD><TD><b><font color=#3333CC><p>Putative bacteriocin (67 aas; 1 TMS)</p></TD><TD><b><font color=#3333CC><p>Firmicutes</p></TD><TD><b><font color=#3333CC><p>Putative bacteriocin of <em>Clostridium perfringens </em>(B1BXT7)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="1.C.90.3.3"></A><A HREF="tcprotein.php?substrate=1.C.90.3.3&tcname=">1.C.90.3.3</a></TD><TD><b><font color=#3333CC><p>Putative bacteriocin (87 aas; 2 TMSs)</p></TD><TD><b><font color=#3333CC><p>Firmicutes</p></TD><TD><b><font color=#3333CC><p>Putative bacteriocin of <em>Enterococcus faecium</em> (C9BRP5)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR><TR bgcolor="#99ccff"><TD><b><A NAME="1.C.90.3.4"></A><A HREF="tcprotein.php?substrate=1.C.90.3.4&tcname=">1.C.90.3.4</a></TD><TD><b><font color=#3333CC><p>Putative bacteriocin (98 aas; 2 TMSs)</p></TD><TD><b><font color=#3333CC><p>Firmicutes</p></TD><TD><b><font color=#3333CC><p>Putative bacteriocin of <em>Streptococcus pneumoniae</em> (A5MY21)</p></TD></TR><TR bgcolor="#ffffff" valign=top><TD COLSPAN=4 valign=top>&nbsp;</CENTER></TD></TR></TABLE>
</CENTER>
</BODY>
</HTML>
